Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Sarana Meditama Metropolitan Tbk. (SAME) Price & Performance

UBC Medical Indonesia Tbk.Trade
Sarana Meditama Metropolitan Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Sarana Meditama Metropolitan Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp161 (market cap 635.95B, 1.34M 24h volume), while Sarana Meditama Metropolitan Tbk. trades at Rp296 (market cap 5.15T, 335.5K 24h volume). The key difference: Sarana Meditama Metropolitan Tbk. is far larger — about 8.1× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (1.34M versus 335.5K). Which is the better fit depends on your goals.

LABSSAME
Market Cap
635.95B5.15T
Volume
1.34M335.5K
Lot
13.4K3.36K
Turnover
215.64M99.9M
Average Price
160.93297.77
Value
215.64M99.9M
Indicative Equilibrium Price
161296
Indicative Equilibrium Volume
17275

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
SAME
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Sarana Meditama Metropolitan Tbk.

PT Sarana Meditama Metropolitan (the Company) was established based on Notarial Deed No. 27 of Budiarti Karnadi, S.H., dated November 13, 1984

Read more on SAME